Navigation Links
AWWA Urges Science-Based Approach in Addressing Pharmaceutical Compounds in Water
Date:4/15/2008

Expert from Southern Nevada Water Authority testifies before Senate subcommittee

WASHINGTON, April 15 /PRNewswire-USNewswire/ -- To responsibly address the issue of pharmaceutical compounds in drinking water, scientists must know at what concentration these substances impact human health, not simply whether they can be detected, a leading expert today told a U.S. Senate subcommittee.

Testifying on behalf of the American Water Works Association (AWWA), Shane Snyder, Ph.D., research and development project manager for Southern Nevada Water Authority, stressed that advanced analytical methods allow scientists to detect substances that would have been impossible to find only a few years ago.

The hearing before the Senate Environment and Public Works Subcommittee on Transportation, Safety, Infrastructure Security, and Water Quality, was scheduled following recent media reports about trace levels of pharmaceutical compounds in drinking water. Snyder has served as principal investigator for many research projects related to the trace-level detection, removal, and toxicology of pharmaceuticals in water supplies.

"I can tell you with absolute certainty that, if we regulate contaminants based upon detection rather than health effects, we are embarking on a futile journey without end," Snyder said.

Pharmaceutical compounds should instead be considered within the framework of the U.S. Environmental Protection Agency's (EPA) Contaminant Candidate List process, Snyder said. That process identifies candidates for new drinking water standards through a science-driven process given the public confidence that the regulations they pay for are necessary, reasonable, and protect public health. Similarly, EPA's Unregulated Contaminant Monitoring Rule provides a framework for decisions concerning testing and reporting to customers about contaminants that are not currently regulated.

Snyder referred to research he has conducted that found the highest concentration of any pharmaceutical compound detected in U.S. drinking waters to be approximately 5 million times lower than one would take in a medical dose. He described that amount as roughly equivalent to one-half of an inch in the distance between the earth and the moon, or in terms of time, approximately one second in approximately 750 years.

Snyder's testimony suggested a number of other actions to address the issue, including:

-- Work among EPA, states, utilities and others to develop policies that minimize contamination of source waters by pharmaceutical products and other contaminants.

-- Encouragement of pharmaceutical take-back programs that reduce flushing of unused medications. Snyder noted that these programs are likely to only address a small part of the concern, however, since pharmaceutical compounds pass through humans and into the wastewater stream.

-- Support for increasing EPA's drinking water health effects research budget to levels at least equivalent to the air pollution health effects research budget.

"To date, no peer reviewed published research has found ill effects on humans from pharmaceuticals in the environment at the trace levels we have seen in drinking water," Snyder said. "However, drinking water providers would like to see more research on this matter, so that we can either take appropriate action to address an actual health risk if there is one, or reassure the public that there is not one."

AWWA's complete testimony is available at: http://epw.senate.gov/public/index.cfm?FuseAction=Files.View&FileStore_id=f 6376de2-be60-4bcf-89b3-80a51ae1750e

AWWA is the authoritative resource for knowledge, information, and advocacy to improve the quality and supply of water in North America and beyond. AWWA is the largest organization of water professionals in the world. AWWA advances public health, safety and welfare by uniting the efforts of the full spectrum of the entire water community. Through our collective strength we become better stewards of water for the greatest good of the people and the environment.


'/>"/>
SOURCE American Water Works Association
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
2. AIDS Healthcare Foundation Applauds City Commissioners Support of Diversity, Urges Call for Mayors Resignation
3. National Council on Disability Urges Congress to Support Americans with Disabilities Act Restoration
4. Health IT Now! Coalition Urges Congress to Pass Health Information Technology Bill This Year
5. SHRM Testimony Urges Congress to Fix FMLA
6. AMA Urges Congress to Stop Medicare Cuts
7. APHA Urges President Bush to Reconsider Unfounded Basis for SCHIP Veto
8. Catholic Charities USA Calls on Congress and the President to Protect the Health of Children; Urges President Not to Veto Vitally Important Bill
9. APHA Urges President Bush Not To Veto CHIP; Were Only One Signature Away from Protecting the Health of Our Children
10. Health Secretary Urges Pennsylvanians to Get a Flu Shot
11. American Diabetes Association Urges Congress to Pass ADA Restoration Act, Help End Employment Discrimination Against Americans with Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... Cambridge, MA (PRWEB) , ... December 08, 2016 , ... ... decreases in medical payments per workers’ compensation claim in 2013 and 2014, according to ... Workers Compensation Research Institute (WCRI) . , According to the study, medical payments per ...
(Date:12/8/2016)... ... December 08, 2016 , ... The Dianne Michael Insurance Agency, ... Hamilton County, is embarking on a charity drive with the aim of generating ... for orphaned or neglected senior dogs in the Cincinnati region, and LuvFurMutts volunteers ...
(Date:12/8/2016)... ... December 08, 2016 , ... Coffey Agencies, a locally owned ... clients in the northern Alabama and Georgia regions, is embarking on a charity ... Works has built a network of support and education facilities to develop and ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... Kenall Manufacturing, ... new MedMaster™ MPCNGX . The MPCNGX is a multi-function, sealed, LED luminaire that ... amount of light where and when it’s needed. , A 2’ x ...
(Date:12/7/2016)... Atlanta, Georgia (PRWEB) , ... ... ... announced today it has acquired Presence Technology, S.L. (“Presence”) for a purchase ... certain price adjustments and other considerations. Presence’s annual revenue is approximately $13.2 ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Dec. 8, 2016  Valeant Pharmaceuticals International, Inc. ... ("Valeant") today announced positive results from a Phase ... assess the safety and efficacy of IDP-118 (halobetasol ... plaque psoriasis. Within the Phase ... to severe psoriasis, IDP-118 showed statistical significance to ...
(Date:12/8/2016)... Mederi Therapeutics Inc . hat die behördliche Zulassung durch die CFDA sowie ... – in China angekündigt. ... ... Live Stretta procedure performed and broadcast during the Chinese Congress ... Union Hospital ...
(Date:12/8/2016)... , Dec. 8, 2016  Boehringer Ingelheim announced today ... Equality Index (CEI). This is the ninth time that ... designated as a Best Place to Work for LGBT ... CEI is a national benchmarking report on corporate policies ... bisexual and transgender (LGBT) employees. "We ...
Breaking Medicine Technology: